Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
The Overview: August 2026
September is Ovarian and Gynecologic Cancer Awareness Month—a time for our community to unite, raise awareness, and push forward in the search for better treatments and cures. This year, that push forward took a major step. In May, we launched the Research Exchange, a new kind of online community that represents a fundamental shift in how … Continued
OCRA’s Ovarian Cycle Rio Grande Valley Gears Up for Year 11 (KRGV-TV)
Ovarian Cycle is back in Rio Grande Valley on September 19, and KRGV-TV Channel 5 News (ABC) recently sat down with Marlynn Olivarez, organizer of the fundraiser, to talk about the event and why it matters. Over the past 10 years, the Rio Grande Valley community has raised more than $66,000 for ovarian and gynecologic cancer research … Continued
The FDA Wants to Hear From You at OCRA’s Online Conference
Submit Your Questions for the FDA Listening Session On September 16–17, Ovarian Cancer Research Alliance (OCRA) will host the International Gynecologic Cancer Conference®, the largest conference dedicated to the gynecologic cancer community. Day 2 features a special opportunity: a Listening Session with leaders from the U.S. Food and Drug Administration (FDA). Ask questions about the FDA’s … Continued